SpyGlass Pharma, Inc.
SGPNasdaqCIK 1778922HealthcareFiscal year ends Dec 31
Reports and events: 17 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1920:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001778922-26-000052 |
| 2026-10-0112:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001778922-26-000049 |
| 2026-08-0620:37 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001778922-26-000045 |
| 2026-08-0620:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001778922-26-000044 |
| 2026-05-1420:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001778922-26-000035 |
| 2026-05-1420:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001778922-26-000033 |
| 2026-03-2621:23 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001778922-26-000020 |
| 2026-03-2620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001778922-26-000018 |
| 2026-03-0920:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001778922-26-000004 |
| 2026-02-1700:21 ET | SCHEDULE 13D | Ownership report, active investor | 0001346824-26-000061 |
| 2026-02-1323:21 ET | SCHEDULE 13D | Ownership report, active investor | 0001072613-26-000183 |
| 2026-02-1321:05 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-051323 |
| 2026-02-1321:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-008073 |
| 2026-02-1023:29 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-045048 |
| 2026-02-0921:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006460 |
| 2026-01-2920:05 ET | S-1/A | Registration statement, amended | 0001628280-26-004091 |
| 2026-01-1620:10 ET | S-1 | Registration statement | 0001628280-26-002356 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.